Ubs Asset Management Americas Inc Apellis Pharmaceuticals, Inc. Transaction History
Ubs Asset Management Americas Inc
- $417 Billion
- Q4 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 212,887 shares of APLS stock, worth $5.28 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
212,887
Previous 191,065
11.42%
Holding current value
$5.28 Million
Previous $5.51 Million
23.28%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding APLS
# of Institutions
302Shares Held
123MCall Options Held
2.63MPut Options Held
845K-
Avoro Capital Advisors LLC New York, NY12.2MShares$303 Million5.68% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$295 Million17.73% of portfolio
-
Wellington Management Group LLP Boston, MA11.8MShares$293 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$249 Million0.01% of portfolio
-
Morgan Stanley New York, NY9.63MShares$239 Million0.02% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $2.73B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...